Clinical Trial Update: A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of radiotherapy in rectal cancer using oxaliplatin and capecitabine, with or without cetuximab. No results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN